The bulletin of the Yamaguchi Medical School
Continued by：Medical Science & Innovation
EISSN：2758-5441
Back to Top
Permalink : https://petit.lib.yamaguchi-u.ac.jp/2903
The bulletin of the Yamaguchi Medical School Volume 56 Issue 1-2
published_at 2009
Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients
Currents status and prospects of autologous bone marrow cell infusion therapy for liver cirrhosis patients
About This Article
Descriptions
We developed a novel cell therapy (ABMi therapy) using autologous bone marrow cells for liver cirrhosis patients. Our study depends on the findings from basic studies using GFP/CCl4 models. Beginning in November 2003, we started clinical trials of ABMi therapy and found it to be safe and effective for liver cirrhosis patients. Multicenter trials in Japan and Korea have also shown the effectiveness of ABMi therapy. In this review, we discuss translational research for the development of ABMi therapy for liver cirrhosis patients.
Creator Keywords
ABMi therapy
bone marrow cell
regeneration
cell therapy
liver cirrhosis
Other Article